UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program vs Discovery MI Gen2
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by Canon Medical Systems Corporation
VS
AI Verdict
Tool A, UltraExtend NX CUW-U001S V2.0, is an AI-enabled software for offline analysis of cardiac ultrasound images, focusing on motion tracking and measurement. Tool B, Discovery MI Gen2, is a complete digital PET/CT system that uses deep-learning AI for superior diagnostic imaging across oncology, neurology, and cardiology. While both utilize AI in cardiology, Tool A is a software solution for existing ultrasound data, whereas Tool B is a comprehensive imaging hardware system.
Choose UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program if…
Choose UltraExtend NX CUW-U001S V2.0 if your primary need is advanced, AI-enabled offline analysis of cardiac ultrasound images. This tool excels at precise and reproducible cardiac quantification, 2D and 3D wall motion tracking, and planning complex procedures based on 3D TEE data, all while optimizing workflow by freeing up your ultrasound machine for other tasks.
View UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program →Choose Discovery MI Gen2 if…
Choose Discovery MI Gen2 if you require a comprehensive, next-generation digital PET/CT system for superior diagnostic imaging across oncology, neurology, and cardiology. This system offers high sensitivity, deep-learning based image reconstruction (TrueFidelity™), and advanced motion correction (MotionFree) to improve small lesion detectability, reduce scan times, and lower injected dose.
View Discovery MI Gen2 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Discovery MI Gen2 |
|---|---|---|
| Pricing | Contact for pricing | Contact vendor for pricing |
| Deployment | On-premise | On-premise (physical hardware) |
| FDA Status | Yes AI-estimated | 1 AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Discovery MI Gen2 |
|---|---|---|
| Tool Name | UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program | Discovery MI Gen2 |
| Company | Canon Medical Systems Corporation | GE HealthCare |
| Description | FDA-cleared AI-enabled ultrasound image analysis program. Provides advanced cardiac motion tracking and measurement, facilitating offline analysis and optimizing workflow for physicians in hospital and clinical settings. | Next-generation digital PET/CT system that leverages deep-learning AI, high sensitivity, and advanced motion correction to deliver superior diagnostic imaging for oncology, neurology, and cardiology. |
| Categories | Cardiology AI | Cardiology AI, Neurology AI, Oncology AI |
| Specialties | Cardiology, Cardiothoracic Surgery | Nuclear Medicine, Oncology, Radiology |
| Key Features | AI-enabled advanced cardiac motion tracking and measurement; 2D and 3D Wall Motion Tracking with Full-assist function; Auto EF LV with Full-assist functions for cardiac analysis; Post-processing analysis of ultrasound images; Complete offline workflow for data organization, review, analysis, documentation, and reporting; Leverages Canon's raw data architecture for streamlined workflow; Precise and reproducible cardiac quantification; Robust tools for planning complex procedures (e.g., THV deployment, clipping) based on 3D TEE data | LightBurst Digital Detector with scalable axial FOV up to 30 cm; High sensitivity (up to 125% increase, 30 cps/kBq); TrueFidelityu2122 deep-learning based image reconstruction; Q.Clear quantitation for accurate SUV measurements and noise reduction; MotionFree digital respiratory motion management solution; Automated patient positioning system (Auto IN); Reduced scan times (up to 50% reduction) and injected dose (up to 50% reduction); Improved small lesion detectability (up to 41% increase) |
Videos
Demos, reviews, and walkthroughs featuring UltraExtend NX CUW-U001S V2.0 Ultrasound Image Analysis Program and Discovery MI Gen2.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
UltraExtend NX focuses on an offline workflow for post-processing and analysis of ultrasound images, leveraging Canon's raw data architecture for streamlined data organization and reporting. Discovery MI Gen2, as a PET/CT system, would integrate by providing diagnostic images and quantitative data that would then be incorporated into the patient's record, likely through standard imaging protocols and PACS systems.
UltraExtend NX emphasizes precise and reproducible cardiac quantification through its AI-enabled advanced cardiac motion tracking and measurement. Discovery MI Gen2 leverages TrueFidelityu2122 deep-learning based image reconstruction and Q.Clear quantitation to improve small lesion detectability and provide accurate SUV measurements, enhancing diagnostic accuracy across oncology, neurology, and cardiology.
UltraExtend NX offers a complete offline workflow with full-assist functions for cardiac analysis, suggesting features designed to aid in physician use. Discovery MI Gen2 incorporates an automated patient positioning system and aims for reduced scan times, which could contribute to a more efficient workflow once the system is understood.
UltraExtend NX provides a complete offline workflow for data organization, review, analysis, documentation, and reporting, which can offer a degree of control over data handling. Discovery MI Gen2, as a physical hardware system, would rely on the robust security protocols of the healthcare institution's network and IT infrastructure, in addition to any built-in system-level security features.
For UltraExtend NX, considerations would include standardizing the offline workflow, data transfer protocols, and physician training across multiple sites. For Discovery MI Gen2, multi-site rollout would involve logistical planning for hardware installation, integration with existing PACS and EHR systems at each location, and comprehensive training for nuclear medicine, oncology, and radiology teams.
UltraExtend NX provides robust tools for planning complex procedures like THV deployment and clipping, based on 3D TEE data. Discovery MI Gen2 offers significant clinical advantages through reduced scan times (up to 50% reduction) and injected dose (up to 50% reduction), which can improve patient comfort and safety while maintaining high image quality.